866-997-4948(US-Canada Toll Free)

Methicillin-resistant Staphylococcus aureus (MRSA) - Epidemiology Forecast to 2025

Published By :

DelveInsight

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 40 Pages

DelveInsight Methicillin-resistant Staphylococcus aureus (MRSA) - Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Methicillin-resistant Staphylococcus aureus (MRSA) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Methicillin-resistant Staphylococcus aureus (MRSA) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Methicillin-resistant Staphylococcus aureus (MRSA). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Scope of the Report
The Report includes the prevalent population and how will it change over the next eight years.
Prevalent or incident cases segmented by age and sex.
Coverage of key Methicillin-resistant Staphylococcus aureus (MRSA) subpopulations and its prevalent or incident cases
The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Methicillin-resistant Staphylococcus aureus (MRSA) market.
Identifying prevalent patient populations as well as risk factors in the global Methicillin-resistant Staphylococcus aureus (MRSA) market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Methicillin-resistant Staphylococcus aureus (MRSA) therapeutics in each of the markets covered.
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Methicillin-resistant Staphylococcus aureus (MRSA) Overview
Methicillin-resistant Staphylococcus aureus (MRSA) Definition
Pathophysiology
Symptoms
5. Etiology
6. Risk Factors Associated with Methicillin-resistant Staphylococcus aureus (MRSA)
7. Disease Burden & Unmet Need in the Market
8. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2015-2025
Prevalent & Incident Cases by Category-2015-2025
Age-Specific Prevalent/ Incident Cases of Methicillin-resistant Staphylococcus aureus (MRSA)
Sex-Specific Prevalent/Incident Cases of Methicillin-resistant Staphylococcus aureus (MRSA)
Disease Type Specific Prevalent/Incident Cases of Methicillin-resistant Staphylococcus aureus (MRSA)
9. Prevalent & Incident Cases by 7 MM-2015-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of United States-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of United Kingdom-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of Germany-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of France-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of Spain-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of Italy-2025
Methicillin-resistant Staphylococcus aureus (MRSA) Epidemiology of Japan-2025
10. Key Takeaways
11. Appendix
12. Report Methodology
13. Consulting Services




List of Table

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Methicillin-resistant Staphylococcus aureus (MRSA) Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA)(Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Japan (2015-2025)

List of Chart

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Methicillin-resistant Staphylococcus aureus (MRSA) Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, US (2015-2025)
Figure 7: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Germany (2015-2025)
Figure 13: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, France (2015-2025)
Figure 16: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Italy (2015-2025)
Figure 19: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Spain (2015-2025)
Figure 22: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Methicillin-resistant Staphylococcus aureus (MRSA) By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Methicillin-resistant Staphylococcus aureus (MRSA) Sub-population, Japan (2015-2025)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *